[Focusing on patient safety and quality of care, exploring long-term antimicrobial stewardship]

Y Ge; J Zhou; B Zhang; D Mei; Y C Xu; X J Ma

doi:10.3760/cma.j.cn112138-20220509-00351

[Focusing on patient safety and quality of care, exploring long-term antimicrobial stewardship]

Zhonghua Nei Ke Za Zhi. 2022 Oct 1;61(10):1091-1094. doi: 10.3760/cma.j.cn112138-20220509-00351.

[Article in Chinese]

Authors

Y Ge¹, J Zhou², B Zhang³, D Mei³, Y C Xu⁴, X J Ma¹

Affiliations

¹ Department of Infectious Disease, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
² Department of Medical Record, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
³ Pharmacy Department, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.
⁴ Laboratory Department, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing 100730, China.

PMID: 36207964
DOI: 10.3760/cma.j.cn112138-20220509-00351

Abstract

感染性疾病对人类的威胁始终存在。耐药病原微生物对公众健康的威胁已经成为现实挑战。以患者安全和医疗质量为核心兼顾合理控费的抗菌药物管理模式已被公认为遏制细菌耐药的全球性战略。我国自2004年开始的抗菌药物管理已经取得了世人瞩目的成就。随着医疗支付模式变革的不断深入，医疗机构在今后如何不断改进和完善以持续做好抗菌药物管理（AMS）是患者、国家、医疗机构等多方共同关注的。本文对国内外AMS模式进行研究，结合多年实践，提出进一步做好AMS的思考，供业内探讨。.

MeSH terms

Anti-Bacterial Agents / therapeutic use
Antimicrobial Stewardship*
Humans
Long-Term Care
Patient Safety

Substances

Anti-Bacterial Agents